James Wymer

3.4k total citations
55 papers, 1.6k citations indexed

About

James Wymer is a scholar working on Neurology, Genetics and Speech and Hearing. According to data from OpenAlex, James Wymer has authored 55 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Neurology, 16 papers in Genetics and 16 papers in Speech and Hearing. Recurrent topics in James Wymer's work include Amyotrophic Lateral Sclerosis Research (24 papers), Neurogenetic and Muscular Disorders Research (16 papers) and Dysphagia Assessment and Management (16 papers). James Wymer is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (24 papers), Neurogenetic and Muscular Disorders Research (16 papers) and Dysphagia Assessment and Management (16 papers). James Wymer collaborates with scholars based in United States, Italy and Israel. James Wymer's co-authors include Laure Aurelian, Theodore D. Chung, Phillip J. Albrecht, Frank L. Rice, Emily K. Plowman, Zachary Simmons, Charles A. Thornton, Carolyn McClain, Richard T. Moxley and Quanzhi Hou and has published in prestigious journals such as Nature Genetics, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

James Wymer

50 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Wymer United States 21 520 416 400 321 248 55 1.6k
Shinsuke Fujioka Japan 23 991 1.9× 353 0.8× 362 0.9× 387 1.2× 103 0.4× 113 1.6k
Gregor Kuhlenbäumer Germany 29 1.1k 2.2× 254 0.6× 669 1.7× 469 1.5× 174 0.7× 106 2.4k
Johanna Palmio Finland 27 465 0.9× 168 0.4× 851 2.1× 638 2.0× 134 0.5× 76 2.0k
Riccardo Ruffoli Italy 17 600 1.2× 303 0.7× 300 0.8× 471 1.5× 126 0.5× 48 1.4k
H. A. Jinnah United States 32 1.1k 2.2× 221 0.5× 1.1k 2.7× 930 2.9× 499 2.0× 55 2.8k
Tomasz Brudek Denmark 21 626 1.2× 266 0.6× 478 1.2× 327 1.0× 127 0.5× 47 1.5k
Jung‐Ick Byun South Korea 26 1.2k 2.4× 210 0.5× 430 1.1× 241 0.8× 430 1.7× 123 2.5k
Erica L. Unger United States 21 381 0.7× 144 0.3× 155 0.4× 179 0.6× 280 1.1× 46 1.1k
Yoshiki Adachi Japan 20 342 0.7× 340 0.8× 388 1.0× 284 0.9× 26 0.1× 62 1.3k
Hideki Ishizu Japan 24 814 1.6× 564 1.4× 338 0.8× 213 0.7× 22 0.1× 94 1.6k

Countries citing papers authored by James Wymer

Since Specialization
Citations

This map shows the geographic impact of James Wymer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Wymer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Wymer more than expected).

Fields of papers citing papers by James Wymer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Wymer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Wymer. The network helps show where James Wymer may publish in the future.

Co-authorship network of co-authors of James Wymer

This figure shows the co-authorship network connecting the top 25 collaborators of James Wymer. A scholar is included among the top collaborators of James Wymer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Wymer. James Wymer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wymer, James, et al.. (2024). Diagnoses of muscular dystrophy in a veterans health system. Muscle & Nerve. 70(2). 273–278.
3.
Gray, Lauren Tabor, Eduardo Locatelli, Terrie Vasilopoulos, James Wymer, & Emily K. Plowman. (2023). Dextromethorphan/quinidine for the treatment of bulbar impairment in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology. 10(8). 1296–1304. 4 indexed citations
4.
Wymer, James, et al.. (2023). Respiratory therapies for Amyotrophic Lateral Sclerosis: A state of the art review. Chronic Respiratory Disease. 20. 4073600235–4073600235. 12 indexed citations
5.
Pattee, Gary L., Angela Genge, Philippe Couratier, et al.. (2023). Oral Edaravone – Introducing a Flexible Treatment Option for Amyotrophic Lateral Sclerosis. Expert Review of Neurotherapeutics. 23(10). 859–866. 15 indexed citations
6.
Robison, Raele, Lauren DiBiase, James Wymer, & Emily K. Plowman. (2022). Functional Lingual Pressure Thresholds for Swallowing Safety and Efficiency Impairments in Amyotrophic Lateral Sclerosis. Dysphagia. 38(2). 676–685. 7 indexed citations
7.
Staats, Kim A., David Borchelt, Malú G. Tansey, & James Wymer. (2022). Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis. Molecular Neurodegeneration. 17(1). 11–11. 49 indexed citations
8.
Sajjadi, Elaheh, et al.. (2021). Acute intermittent hypoxia and respiratory muscle recruitment in people with amyotrophic lateral sclerosis: A preliminary study. Experimental Neurology. 347. 113890–113890. 17 indexed citations
9.
Arcila-Londono, Ximena, David Walk, Scott Vota, et al.. (2019). General Characteristics of edaravone Use in the Natural History of ALS and Other Motor Neuron Disorders Consortium Dataset (NeuroBANK ) (S5.006). Neurology. 92(15_supplement). 1 indexed citations
11.
Smith, Richard, Erik P. Pioro, Kathleen Myers, et al.. (2017). Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial. Neurotherapeutics. 14(3). 762–772. 76 indexed citations
12.
Zhao, Peng, Travis P. Barr, Quanzhi Hou, et al.. (2008). Voltage-gated sodium channel expression in rat and human epidermal keratinocytes: Evidence for a role in pain. Pain. 139(1). 90–105. 150 indexed citations
13.
Panitch, Hillel, Ronald A. Thisted, Richard Smith, et al.. (2006). Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis. Annals of Neurology. 59(5). 780–787. 126 indexed citations
14.
Thisted, Ronald A., Leslie J. Klaff, Sherwyn Schwartz, et al.. (2006). Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: A 29-day, multicenter, open-Label, dose-escalation study. Clinical Therapeutics. 28(10). 1607–1618. 26 indexed citations
15.
Thornton, Charles A., James Wymer, Zachary Simmons, Carolyn McClain, & Richard T. Moxley. (1997). Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene. Nature Genetics. 16(4). 407–409. 174 indexed citations
16.
Riggs, Jack E., Leena Ketonen, James Wymer, et al.. (1994). Acute and Delayed Cerebral Infarction After Wasp Sting Anaphylaxis. Clinical Neuropharmacology. 17(4). 384–384. 22 indexed citations
17.
Smith, Cynthia C., Michael Kulka, James Wymer, Theodore D. Chung, & Laure Aurelian. (1992). Expression of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for virus growth and neoplastic transformation. Journal of General Virology. 73(6). 1417–1428. 23 indexed citations
19.
Smith, Cynthia C., James Wymer, Jianhua Luo, & Laure Aurelian. (1991). Genomic sequences homologous to the protein kinase region of the bifunctional herpes simplex virus type 2 protein ICP10. Virus Genes. 5(3). 215–226. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026